Skip to main content

Scleroderma, An Issue of Rheumatic Disease Clinics

  • 1st Edition, Volume 41-3 - August 3, 2015
  • Author: Maureen D. Mayes
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 3 2 3 - 3 9 3 5 4 - 6
  • eBook ISBN:
    9 7 8 - 0 - 3 2 3 - 3 9 3 5 5 - 3

Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. Hardening of the skin is one of the mo… Read more

Scleroderma, An Issue of Rheumatic Disease Clinics

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. Hardening of the skin is one of the most visible manifestations of the disease. It’s estimated that about 300,000 Americans have scleroderma. About one third of those people have the systemic form of scleroderma. Since scleroderma presents with symptoms similar to other autoimmune diseases, diagnosis is difficult. This issue will cover: The Genetic Basis of SSc: Genetics, Epigenetics, Mechanisms of Pathogenesis – linking fibrosis, vasculopathy and immune dysregulation, The Role of Autoantibodies in Diagnosis and Prognosis/survival; Managing Raynaud’s phenomenon and ischemic ulcers, managing SSc Lung Disease, Monitoring for and Managing Pulmonary Arterial Hypertension, and many more!